Bhang Announces Delayed Filing of Annual Disclosure Documents
MIAMI, April 24, 2020 (GLOBE NEWSWIRE) — Bhang Inc. (“Bhang” or the “Company“) (CSE: BHNG) (OTCQX: BHNGF), a global cannabis […]
Canadian Metals Inc.: Stéphane Leblanc to File Early Warning Report
MONTREAL, April 24, 2020 (GLOBE NEWSWIRE) — Canadian Metals Inc. (“CME” or the “Company”) (CSE: CME) today reports that Mr. […]
Draganfly Concludes COVID-19 Social Distancing Test with Westport Police Department
Los Angeles, CA, April 24, 2020 (GLOBE NEWSWIRE) — Draganfly Inc. (CSE: DFLY) (OTCQB: DFLYF) (FSE: 3U8) (“Draganfly” or the […]
TILT Holdings – Unaware of Any Material Change
CAMBRIDGE, Mass., April 24, 2020 (GLOBE NEWSWIRE) — At the request of IIROC, TILT Holdings Inc. (“TILT” or the “Company”) […]
AgraFlora Organics complète son premier lot d’huile et de distillat de CBD
VANCOUVER, Colombie-Britannique, 24 avr. 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (« AgraFlora » ou la « Société ») (CSE : AGRA) (Frankfurt: PU31) […]
REPEAT – AgraFlora Organics Completes First Batch of CBD Oil and CBD Distillate
VANCOUVER, British Columbia, April 24, 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: [...]
Algernon obtiene aprobación regulatoria y de ética para estudio en Fase II de Ifenprodil en seres humanos con COVID-19 en Corea del Sur
VANCOUVER, Columbia Británica, April 24, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (la “Compañía” o […]
Algernon, 이펜프로딜 코로나19 인간 대상 임상시험의 한국 내 실시와 관련된 규제기관 및 윤리적 승인 획득
캐나다 밴쿠버, April 24, 2020 (GLOBE NEWSWIRE) — 임상 단계 제약 개발사인 Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: […]
Algernon Recebe Aprovação Regulatória e de Ética para Estudo de Fase 2 do Ifenprodil COVID-19 Humano na Coreia do Sul
VANCOUVER, British Columbia, April 24, 2020 (GLOBE NEWSWIRE) — A Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (a […]
アルジェノン、韓国で実施するCOVID-19治療薬としてのイフェンプロジル第II相臨床試験に規制当局による承認と倫理審査による承認を取得
ブリティッシュコロンビア州バンクーバー発, April 24, 2020 (GLOBE NEWSWIRE) — 臨床病期向け治療薬開発会社のアルジェノン製薬 (Algernon Pharmaceuticals Inc.) (CSE: AGN) (フランクフルト証券取引所: AGW) (OTCQB: AGNPF) (以下、「同社」または「アルジェノン」) [...]
